Rating History for Pacific Biosciences of California (pacb) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/22/2024 | Rachel Vatnsdal | Downgrade | Neutral (Overweight) |
N/A (N/A) |
1.46 (1.14) |
-21.92% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||


